Daniel Spiegelman
Follow
Get notifications in MyBN when activity occurs.
Daniel Spiegelman
Non-Executive Director / Opthea
Daniel Spiegelman has industry knowledge and US corporate governance, compliance and financial management experience. He has held numerous executive and board roles, including as audit and risk committee chair, with several US public and private companies.
Mr Spiegelman has experience in the biotechnology industry who has provided strategic financial management, and has worked in a number of life science companies during his career.
Mr Spiegelman has experience in the biotechnology industry who has provided strategic financial management, and has worked in a number of life science companies during his career.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1002nd | Opthea | -19% | -2% |
| 1113th | QuickFee | -26% | |
| 1329th | Zoono Group | -41% | -13% |
| 1370th | 8Common | -43% | 3% |
| 1809th | Galilee Energy | -76% | -39% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 700th |  | Opthea | $19.1m |
| 816th | | Galilee Energy | $7.8m |
| 817th | | Zoono Group | $7.8m |
| 819th | | QuickFee | $7.6m |
| 821st | | 8Common | $7.5m |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Non-Executive Director, Opthea | 03 Nov 2020 |
